Nature Highlights Self-Driving Labs and Advanced Immunotherapies Among Top Technologies to Watch in 2025 1 year ago AnaIn BreakthroughsClinical TrialsTechnology
GSK’s Jemperli Receives EMA Approval for First-Line Endometrial Cancer Treatment 1 year ago AnaIn Clinical TrialsFeatured AnalysisLeadersPharma Industry Updates
FDA Accepts Arrowhead’s New Drug Application for Plozasiran in Treating Familial Chylomicronemia Syndrome 1 year ago AnaIn Biopharma HighlightsFDA Approvals
FDA Approves Datopotamab Deruxtecan (Datroway) for HR-Positive, HER2-Negative Breast Cancer 1 year ago AnaIn FDA ApprovalsInnovationLeadersResearch Updates
Evaxion Completes Dosing in Phase II Trial of Personalized Cancer Vaccine EVX-01, Paving the Way for AI-Driven Oncology 1 year ago AnaIn AI & DataBreakthroughsClinical Trials
Avance Clinical Captures Australia’s Early-Phase CRO Market, While Idorsia Prepares Strategic Pivot at JPM Week 1 year ago AnaIn Biopharma HighlightsResearch UpdatesStartups
FDA Grants Rare Pediatric Designation to ViGeneron’s RP Gene Therapy VG901; EMA Pushes for EU Clinical Trials Transition 1 year ago AnaIn BreakthroughsClinical TrialsResearch Updates
Denali, Agios, Cabaletta and Walden Drive Rare Disease and Immuno-Innovations into the Spotlight at JP Morgan Week 1 year ago AnaIn Breaking NewsBreakthroughsIndustry ConferencesLeadersPeopleTop Stories
Mereo BioPharma Advances Rare Disease Programs with Setrusumab and Alvelestat Milestones 1 year ago AnaIn Biopharma HighlightsBreakthroughsTop Stories
Bio-Path Holdings Gears Up for Dual Progression of Oncology and Obesity Programs in 2025 1 year ago AnaIn Industry ConferencesPeopleResearch Updates
J.P. Morgan Healthcare Conference 2025 Opens with Heavy Security, Heightened Stakes, and Hints of Revival in Biopharma Deal-Making 1 year ago AnaIn Industry ConferencesPeoplePharma Industry Updates
Hoyos Therapeutics Unveils Inhaled mRNA Gene-Silencing Therapy in Landmark Clinical Trial for Asthma 1 year ago AnaIn Top Stories
Stablepharma’s Fridge-Free Vaccine Booster on Track for Clinical Trial in the UK 1 year ago AnaIn Innovation
Vertex Taps Orna Therapeutics’ Lipid Nanoparticle Technology to Advance Gene Editing for Blood Disorders 1 year ago AnaIn PartnershipsPeoplePharma Industry Updates
Cyprium’s CUTX-101 Secures FDA Priority Review: A Defining Moment for Menkes Disease Treatment 1 year ago AnaIn Biopharma HighlightsClinical TrialsFDA Approvals
